Oncology PracticePsilocybin-Assisted Group Therapy Promising for Depression in Cancer PatientsJanuary 18, 2024Patient & Survivor Care
Hematology NewsCRISPR-Based Gene Therapy Earns Beta Thalassemia ApprovalJanuary 18, 2024Bleeding Disorders
Hematology NewsNew Federal Rule for Prior Authorizations a ‘Major Win’ for Patients, DoctorsJanuary 18, 2024Business of MedicinePractice Management
Cisplatin-based regimens associated with improved prognosis in operable TNBCJanuary 17, 2024Breast Cancer
First-line molecular subtype-based precision therapy shows promise in metastatic TNBC in phase 2January 17, 2024Breast Cancer
Leisure-time physical activity may lower premenopausal breast cancer riskJanuary 17, 2024Breast Cancer
Loss of progesterone receptors worsens survival in HER2− inflammatory BCJanuary 17, 2024Breast Cancer
Radiotherapy-pyrotinib-capecitabine combo benefits patients with ERBB2+ BC and brain metastasesJanuary 17, 2024Breast Cancer
Magnetic seeds as effective as guidewire in BC patients undergoing breast-conserving surgeryJanuary 17, 2024Breast Cancer
Bevacizumab, etoposide, and cisplatin before WBRT benefits intractable breast cancer brain metastasesJanuary 17, 2024Breast Cancer
Benign breast disease on percutaneous biopsy increases breast cancer riskJanuary 17, 2024Breast Cancer
Oncology PracticeCMS Okays Payment for Novel AI Prostate TestJanuary 16, 2024Practice ManagementGenitourinary CancerPreventive CarePatient & Survivor CareBusiness of MedicineProstate Cancer
